Cargando…
Co‐testing in cervical screening among 40‐ to 42‐year‐old women is unreasonable
INTRODUCTION: The screening program for cervical cancer in Sweden recommends the use of primary human papillomavirus (HPV) screening for women aged ≥30 to 65 years. Co‐testing with both HPV analysis and cytology is recommended at the first screening after the age of 40 years. To fulfil co‐testing, a...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564562/ https://www.ncbi.nlm.nih.gov/pubmed/34988970 http://dx.doi.org/10.1111/aogs.14311 |